Informação sobre produto
A 357300 is a novel drug that has been shown to be effective in treating bowel diseases. The drug's mechanism of action is not yet fully understood, but it has been shown to reduce pro-inflammatory cytokines, such as tumor necrosis factor (TNF), and increase anti-inflammatory cytokines, such as IL-10. A 357300 is also thought to inhibit the production of methionine aminopeptidase, which is an enzyme that degrades the amino acid methionine. This leads to higher levels of methionine in the gut, which activates a type of immune cell called a macrophage. Activated macrophages release nitric oxide (NO), which can help treat bowel disease by reducing inflammation and increasing blood flow in the gut. A 357300 has also been found to reduce pain in rats with inflammatory bowel disease by blocking nerve signals from reaching the brain through activation of calcium channels.
A 357300 has not yet been
Propriedades químicas
Consulta técnica sobre: 3D-UPA35807 A 357300
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
